世界のヒトヘルパースウイルス5(HHV-5)薬市場2020-2025:ガンシクロビル、バレリアンギリビル薬、アシクロビル薬、バラシクロビル薬、ホスカルネットナトリウム薬

LP Informationが発行した調査報告書(LPI21MA06301)
◆英語タイトル:Global Human Herpersvirus 5 (HHV-5) Drug Market Growth 2020-2025
◆商品コード:LPI21MA06301
◆発行会社(リサーチ会社):LP Information
◆発行日:2021年1月(※2024年版があります。お問い合わせください。)
◆ページ数:165
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
◆産業分野:医薬品・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,660 ⇒換算¥541,680見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,490 ⇒換算¥812,520見積依頼/購入/質問フォーム
Corporate User(閲覧人数制限なし)USD7,320 ⇒換算¥1,083,360見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はLP Information社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。LP Information社の概要及び新刊レポートはこちらでご確認いただけます。

「ヒトヘルパースウイルス5(HHV-5)薬の世界市場」は、地域的には米州、アジア、欧州、中東・アフリカ市場をカバーしており、種類別には、ガンシクロビル、バレリアンギリビル薬、アシクロビル薬、バラシクロビル薬、ホスカルネットナトリウム薬など、用途別には、免疫不全群集、臓器移植群集、CMVヘルペス群集などに区分してまとめた調査レポートです。ヒトヘルパースウイルス5(HHV-5)薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が含まれています。
・ヒトヘルパースウイルス5(HHV-5)薬の世界市場概要(サマリー)
・ヒトヘルパースウイルス5(HHV-5)薬の企業別販売量・売上
・ヒトヘルパースウイルス5(HHV-5)薬の企業別市場シェア
・ヒトヘルパースウイルス5(HHV-5)薬の世界市場規模 2015年-2020年:種類別(ガンシクロビル、バレリアンギリビル薬、アシクロビル薬、バラシクロビル薬、ホスカルネットナトリウム薬)
・ヒトヘルパースウイルス5(HHV-5)薬の世界市場規模 2015年-2020年:用途別(免疫不全群集、臓器移植群集、CMVヘルペス群集)
・ヒトヘルパースウイルス5(HHV-5)薬の米州市場規模(アメリカ、カナダ、メキシコなど)
・ヒトヘルパースウイルス5(HHV-5)薬のアジア市場規模(日本、中国、韓国、インド、東南アジアなど)
・ヒトヘルパースウイルス5(HHV-5)薬の欧州市場規模(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・ヒトヘルパースウイルス5(HHV-5)薬の中東・アフリカ市場(エジプト、南アフリカ、トルコ、GCC諸国など)
・ヒトヘルパースウイルス5(HHV-5)薬市場の成長要因・課題・動向
・ヒトヘルパースウイルス5(HHV-5)薬の世界市場予測 2021年-2025年
・ヒトヘルパースウイルス5(HHV-5)薬の米州市場予測(アメリカ、カナダ、メキシコなど)
・ヒトヘルパースウイルス5(HHV-5)薬のアジア市場予測(日本、中国、韓国、インド、東南アジアなど)
・ヒトヘルパースウイルス5(HHV-5)薬の欧州市場予測(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・ヒトヘルパースウイルス5(HHV-5)薬の中東・アフリカ市場予測(エジプト、南アフリカ、トルコ、GCC諸国など)
・ヒトヘルパースウイルス5(HHV-5)薬の世界市場予測:種類別(ガンシクロビル、バレリアンギリビル薬、アシクロビル薬、バラシクロビル薬、ホスカルネットナトリウム薬)
・ヒトヘルパースウイルス5(HHV-5)薬の世界市場予測:用途別(免疫不全群集、臓器移植群集、CMVヘルペス群集)
・主要企業分析
【レポートの概要】

According to this study, over the next five years the Human Herpersvirus 5 (HHV-5) Drug market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Human Herpersvirus 5 (HHV-5) Drug business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Human Herpersvirus 5 (HHV-5) Drug market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the Human Herpersvirus 5 (HHV-5) Drug, covering the supply chain analysis, impact assessment to the Human Herpersvirus 5 (HHV-5) Drug market size growth rate in several scenarios, and the measures to be undertaken by Human Herpersvirus 5 (HHV-5) Drug companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Ganciclovir
Valerian Gilivir Drugs
Acyclovir Drugs
Valacyclovir Drugs
Foscarnet Sodium Drugs

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Immunodeficiency Crowd
Organ Transplant Crowd
CMV Herpes Crowd

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Roche
Chongqing Fu’an Pharmaceutical
Livzon Pharmaceuticals
Hubei Branch benefits medicine
GlaxoSmithKline
Sichuan Cologne Pharmaceutical
Haikou Kellett
Upright and clear
On the drug new Asia
Chongqing Winbond (acquisition of Sichuan Mingxin)
Shandong Luo Xin Pharmaceutical
Wuhan Hualong
Qianjiang Pharmaceuticals
Yangtze River Pharmaceutical

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Human Herpersvirus 5 (HHV-5) Drug consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Human Herpersvirus 5 (HHV-5) Drug market by identifying its various subsegments.
Focuses on the key global Human Herpersvirus 5 (HHV-5) Drug manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Human Herpersvirus 5 (HHV-5) Drug with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Human Herpersvirus 5 (HHV-5) Drug submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

【レポートの目次】

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Human Herpersvirus 5 (HHV-5) Drug Consumption 2015-2025
2.1.2 Human Herpersvirus 5 (HHV-5) Drug Consumption CAGR by Region
2.2 Human Herpersvirus 5 (HHV-5) Drug Segment by Type
2.2.1 Ganciclovir
2.2.2 Valerian Gilivir Drugs
2.2.3 Acyclovir Drugs
2.2.4 Valacyclovir Drugs
2.2.5 Foscarnet Sodium Drugs
2.3 Human Herpersvirus 5 (HHV-5) Drug Consumption by Type
2.3.1 Global Human Herpersvirus 5 (HHV-5) Drug Consumption Market Share by Type (2015-2020)
2.3.2 Global Human Herpersvirus 5 (HHV-5) Drug Revenue and Market Share by Type (2015-2020)
2.3.3 Global Human Herpersvirus 5 (HHV-5) Drug Sale Price by Type (2015-2020)
2.4 Human Herpersvirus 5 (HHV-5) Drug Segment by Application
2.4.1 Immunodeficiency Crowd
2.4.2 Organ Transplant Crowd
2.4.3 CMV Herpes Crowd
2.5 Human Herpersvirus 5 (HHV-5) Drug Consumption by Application
2.5.1 Global Human Herpersvirus 5 (HHV-5) Drug Consumption Market Share by Type (2015-2020)
2.5.2 Global Human Herpersvirus 5 (HHV-5) Drug Value and Market Share by Type (2015-2020)
2.5.3 Global Human Herpersvirus 5 (HHV-5) Drug Sale Price by Type (2015-2020)

3 Global Human Herpersvirus 5 (HHV-5) Drug by Company
3.1 Global Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Company
3.1.1 Global Human Herpersvirus 5 (HHV-5) Drug Sales by Company (2018-2020)
3.1.2 Global Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Company (2018-2020)
3.2 Global Human Herpersvirus 5 (HHV-5) Drug Revenue Market Share by Company
3.2.1 Global Human Herpersvirus 5 (HHV-5) Drug Revenue by Company (2018-2020)
3.2.2 Global Human Herpersvirus 5 (HHV-5) Drug Revenue Market Share by Company (2018-2020)
3.3 Global Human Herpersvirus 5 (HHV-5) Drug Sale Price by Company
3.4 Global Human Herpersvirus 5 (HHV-5) Drug Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Human Herpersvirus 5 (HHV-5) Drug Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Human Herpersvirus 5 (HHV-5) Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Human Herpersvirus 5 (HHV-5) Drug by Regions
4.1 Human Herpersvirus 5 (HHV-5) Drug by Regions
4.2 Americas Human Herpersvirus 5 (HHV-5) Drug Consumption Growth
4.3 APAC Human Herpersvirus 5 (HHV-5) Drug Consumption Growth
4.4 Europe Human Herpersvirus 5 (HHV-5) Drug Consumption Growth
4.5 Middle East & Africa Human Herpersvirus 5 (HHV-5) Drug Consumption Growth

5 Americas
5.1 Americas Human Herpersvirus 5 (HHV-5) Drug Consumption by Countries
5.1.1 Americas Human Herpersvirus 5 (HHV-5) Drug Consumption by Countries (2015-2020)
5.1.2 Americas Human Herpersvirus 5 (HHV-5) Drug Value by Countries (2015-2020)
5.2 Americas Human Herpersvirus 5 (HHV-5) Drug Consumption by Type
5.3 Americas Human Herpersvirus 5 (HHV-5) Drug Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Human Herpersvirus 5 (HHV-5) Drug Consumption by Regions
6.1.1 APAC Human Herpersvirus 5 (HHV-5) Drug Consumption by Regions (2015-2020)
6.1.2 APAC Human Herpersvirus 5 (HHV-5) Drug Value by Regions (2015-2020)
6.2 APAC Human Herpersvirus 5 (HHV-5) Drug Consumption by Type
6.3 APAC Human Herpersvirus 5 (HHV-5) Drug Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
7.1 Europe Human Herpersvirus 5 (HHV-5) Drug by Countries
7.1.1 Europe Human Herpersvirus 5 (HHV-5) Drug Consumption by Countries (2015-2020)
7.1.2 Europe Human Herpersvirus 5 (HHV-5) Drug Value by Countries (2015-2020)
7.2 Europe Human Herpersvirus 5 (HHV-5) Drug Consumption by Type
7.3 Europe Human Herpersvirus 5 (HHV-5) Drug Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Human Herpersvirus 5 (HHV-5) Drug by Countries
8.1.1 Middle East & Africa Human Herpersvirus 5 (HHV-5) Drug Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Human Herpersvirus 5 (HHV-5) Drug Value by Countries (2015-2020)
8.2 Middle East & Africa Human Herpersvirus 5 (HHV-5) Drug Consumption by Type
8.3 Middle East & Africa Human Herpersvirus 5 (HHV-5) Drug Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Human Herpersvirus 5 (HHV-5) Drug Distributors
10.3 Human Herpersvirus 5 (HHV-5) Drug Customer

11 Global Human Herpersvirus 5 (HHV-5) Drug Market Forecast
11.1 Global Human Herpersvirus 5 (HHV-5) Drug Consumption Forecast (2021-2025)
11.2 Global Human Herpersvirus 5 (HHV-5) Drug Forecast by Regions
11.2.1 Global Human Herpersvirus 5 (HHV-5) Drug Forecast by Regions (2021-2025)
11.2.2 Global Human Herpersvirus 5 (HHV-5) Drug Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast byRegions
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Human Herpersvirus 5 (HHV-5) Drug Forecast by Type
11.8 Global Human Herpersvirus 5 (HHV-5) Drug Forecast by Application

12 Key Players Analysis
12.1 Roche
12.1.1 Company Information
12.1.2 Human Herpersvirus 5 (HHV-5) Drug Product Offered
12.1.3 Roche Human Herpersvirus 5 (HHV-5) Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Roche Latest Developments
12.2 Chongqing Fu’an Pharmaceutical
12.2.1 Company Information
12.2.2 Human Herpersvirus 5 (HHV-5) Drug Product Offered
12.2.3 Chongqing Fu’an Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Chongqing Fu’an Pharmaceutical Latest Developments
12.3 Livzon Pharmaceuticals
12.3.1 Company Information
12.3.2 Human Herpersvirus 5 (HHV-5) Drug Product Offered
12.3.3 Livzon Pharmaceuticals Human Herpersvirus 5 (HHV-5) Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Livzon Pharmaceuticals Latest Developments
12.4 Hubei Branch benefits medicine
12.4.1 Company Information
12.4.2 Human Herpersvirus 5 (HHV-5) Drug Product Offered
12.4.3 Hubei Branch benefits medicine Human Herpersvirus 5 (HHV-5) Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Hubei Branch benefits medicine Latest Developments
12.5 GlaxoSmithKline
12.5.1 Company Information
12.5.2 Human Herpersvirus 5 (HHV-5) Drug Product Offered
12.5.3 GlaxoSmithKline Human Herpersvirus 5 (HHV-5) Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 GlaxoSmithKline Latest Developments
12.6 Sichuan Cologne Pharmaceutical
12.6.1 Company Information
12.6.2 Human Herpersvirus 5 (HHV-5) Drug Product Offered
12.6.3 Sichuan Cologne Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Sichuan Cologne Pharmaceutical Latest Developments
12.7 Haikou Kellett
12.7.1 Company Information
12.7.2 Human Herpersvirus 5 (HHV-5) Drug Product Offered
12.7.3 Haikou Kellett Human Herpersvirus 5 (HHV-5) Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Haikou Kellett Latest Developments
12.8 Upright and clear
12.8.1 Company Information
12.8.2 Human Herpersvirus 5 (HHV-5) Drug Product Offered
12.8.3 Upright and clear Human Herpersvirus 5 (HHV-5) Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Upright and clear Latest Developments
12.9 On the drug new Asia
12.9.1 Company Information
12.9.2 Human Herpersvirus 5 (HHV-5) Drug Product Offered
12.9.3 On the drug new Asia Human Herpersvirus 5 (HHV-5) Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 On the drug new Asia Latest Developments
12.10 Chongqing Winbond (acquisition of Sichuan Mingxin)
12.10.1 Company Information
12.10.2 Human Herpersvirus 5 (HHV-5) Drug Product Offered
12.10.3 Chongqing Winbond (acquisition of Sichuan Mingxin) Human Herpersvirus 5 (HHV-5) Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Chongqing Winbond (acquisition of Sichuan Mingxin) Latest Developments
12.11 Shandong Luo Xin Pharmaceutical
12.11.1 Company Information
12.11.2 Human Herpersvirus 5 (HHV-5) Drug Product Offered
12.11.3 Shandong Luo Xin Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Shandong Luo Xin Pharmaceutical Latest Developments
12.12 Wuhan Hualong
12.12.1 Company Information
12.12.2 Human Herpersvirus 5 (HHV-5) Drug Product Offered
12.12.3 Wuhan Hualong Human Herpersvirus 5 (HHV-5) Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Wuhan Hualong Latest Developments
12.13 Qianjiang Pharmaceuticals
12.13.1 Company Information
12.13.2 Human Herpersvirus 5 (HHV-5) Drug Product Offered
12.13.3 Qianjiang Pharmaceuticals Human Herpersvirus 5 (HHV-5) Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 Qianjiang Pharmaceuticals Latest Developments
12.14 Yangtze River Pharmaceutical
12.14.1 Company Information
12.14.2 Human Herpersvirus 5 (HHV-5) Drug Product Offered
12.14.3 Yangtze River Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.14.4 Main Business Overview
12.14.5 Yangtze River Pharmaceutical Latest Developments

13 Research Findings and Conclusion



【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のヒトヘルパースウイルス5(HHV-5)薬市場2020-2025:ガンシクロビル、バレリアンギリビル薬、アシクロビル薬、バラシクロビル薬、ホスカルネットナトリウム薬(Global Human Herpersvirus 5 (HHV-5) Drug Market Growth 2020-2025)]についてメールでお問い合わせはこちらでお願いします。